摘要
目的:探讨SBAR结合MDT管理模式对门诊超重糖尿病患者的干预效果。方法:选取萍乡市人民医院2019年1-11月收治的100例门诊超重糖尿病患者作为研究对象,按照随机数字表法将其分为观察组(n=50)和对照组(n=50),对照组采用常规门诊管理,观察组采用SBAR结合MDT管理模式,比较两组管理前、管理3、6、12个月时空腹血糖(FBG)、餐后2 h血糖(2 h PG)、糖化血红蛋白(HbA1c)、甘油三酯(TG)、总胆固醇(TC)、腰围(WC)、体重指数(BMI)以及自我行为管理能力。结果:管理12个月时,观察组FBG、2 h PG均低于对照组,差异均有统计学意义(P<0.05);观察组HbA1c低于对照组,差异有统计学意义(P<0.05);观察组TC、TG均低于对照组,差异均有统计学意义(P<0.05);观察组WC、BMI均低于对照组,差异均有统计学意义(P<0.05);观察组SDSCA评分高于对照组,差异有统计学意义(P<0.05)。结论:SBAR结合MDT管理模式对门诊超重糖尿病患者具有明显作用,可提高血糖及体重控制效果,提高患者自我行为管理能力,临床应用价值高。
Objective:To explore the intervention effect of SBAR combined with MDT management mode on overweight diabetic outpatients.Method:A total of 100 outpatients with overweight diabetes mellitus in Pingxiang People’s Hospital from January to November 2019 were selected and divided into observation group(n=50)and control group(n=50)by random number table method.The control group was treated with routine outpatient management,and the observation group was treated with SBAR combined with MDT management mode.Fasting blood glucose(FBG),2 h postprandial blood glucose(2 h PG),glycosylated hemoglobin(HbA1c),triglyceride(TG),total cholesterol(TC),waist circumference(WC),body mass index(BMI)and self-behavior management ability were compared between the two groups before management,3 months,6 months and 12 months after management.Result:After 12 months of management,FBG and 2 h PG in the observation group were lower than those in the control group(P<0.05);HbA1c in the observation group was lower than that in the control group(P<0.05);TC and TG in the observation group were lower than those in the control group(P<0.05);WC and BMI in the observation group were lower than those in the control group(P<0.05);SDSCA score in the observation group was higher than that in the control group,the difference was statistically significant(P<0.05).Conclusion:SBAR combined with MDT management mode has a significant effect on overweight diabetic outpatients,which can improve the effect of blood glucose and weight control,improve the self behavior management ability of patients,and has high clinical application value.
作者
余怡
文叶
彭方依
YU Yi;WEN Ye;PENG Fangyi(Pingxiang People’s Hospital,Pingxiang 337000,China;不详)
出处
《中国医学创新》
CAS
2021年第31期121-124,共4页
Medical Innovation of China
基金
江西省卫生健康委科技计划项目(202140504)。